Risk of Adverse Events of Live-Attenuated COVID-19 Vaccination Among Atopic Patients.

Chirawat ChiewchalermsriKitchawan HengkrawitPalakorn SrinithiwatWipawee KiatsermkachornOrawin Luecha

Published in: Journal of asthma and allergy (2022)

Atopic patients had more risk of adverse reactions to live-attenuated Oxford/AstraZeneca COVID-19 vaccination. No life-threatening adverse reaction was seen. Physicians should screen atopic risks in people who are getting vaccinated. Atopic patients should be knowledgeable about their risk and how to monitor clinical reactions by themselves.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
sars cov
peritoneal dialysis
primary care
emergency department
risk assessment